(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.14%) $78.05
(5.55%) $2.15
(0.07%) $2 311.20
(-0.12%) $26.80
(0.23%) $964.85
(-0.35%) $0.929
(-1.14%) $10.87
(-0.13%) $0.797
(0.35%) $91.45
2.37% $ 122.18
Live Chart Being Loaded With Signals
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular...
Stats | |
---|---|
Объем за сегодня | 2.06M |
Средний объем | 191 486 |
Рыночная капитализация | 175.45B |
EPS | $0.342 ( 2023-09-29 ) |
Last Dividend | $1.375 ( 2023-05-12 ) |
Next Dividend | $0 ( N/A ) |
P/E | 230.53 |
ATR14 | $1.907 (1.56%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-12 | Fitzgerald Joseph Michael | Sell | 11 660 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Buy | 15 172 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Sell | 15 172 | Common Stock |
2024-01-09 | Mirviss Jeffrey B. | Sell | 15 172 | Stock Option (Right to Buy) |
2024-01-04 | Mirviss Jeffrey B. | Buy | 15 000 | Common Stock |
INSIDER POWER |
---|
-33.84 |
Last 100 transactions |
Buy: 835 783 | Sell: 1 712 211 |
Объем Корреляция
Boston Scientific Корреляция
10 Самые положительные корреляции | |
---|---|
DTC | 0.915 |
CRD-B | 0.903 |
OR | 0.901 |
CRD-A | 0.895 |
NGG | 0.889 |
IBA | 0.889 |
SQSP | 0.877 |
AGI | 0.876 |
BEST | 0.874 |
USX | 0.873 |
10 Самые отрицательные корреляции | |
---|---|
CBU | -0.894 |
SFUN | -0.888 |
FRC-PI | -0.869 |
GLOP-PC | -0.868 |
FRC-PH | -0.867 |
ASPN | -0.865 |
TDCX | -0.865 |
FRC-PM | -0.864 |
FRC-PN | -0.861 |
FRC-PK | -0.861 |
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Boston Scientific Корреляция - Валюта/Сырье
Boston Scientific Финансовые показатели
Annual | 2023 |
Выручка: | $14.24B |
Валовая прибыль: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2023 |
Выручка: | $14.24B |
Валовая прибыль: | $9.90B (69.49 %) |
EPS: | $1.080 |
FY | 2022 |
Выручка: | $12.68B |
Валовая прибыль: | $8.68B (68.44 %) |
EPS: | $0.450 |
FY | 2021 |
Выручка: | $11.89B |
Валовая прибыль: | $8.13B (68.37 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Boston Scientific Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$1.375 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.436 | 2020-08-13 |
Last Dividend | $1.375 | 2023-05-12 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-01 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | $8.31 | -- |
Avg. Dividend % Per Year | 1.01% | -- |
Score | 3.03 | -- |
Div. Sustainability Score | 8.53 | |
Div.Growth Potential Score | 5.22 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|---|---|
2020 | $2.81 | 2.70% |
2021 | $4.13 | 3.80% |
2022 | $0 | 0.00% |
2023 | $1.375 | 1.21% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.121 | 1.500 | 7.59 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0484 | 1.200 | 8.39 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0934 | 1.500 | -0.0732 | -0.110 | [0.1 - 1] |
payoutRatioTTM | 0.00790 | -1.000 | 9.92 | -9.92 | [0 - 1] |
currentRatioTTM | 0.176 | 0.800 | -4.12 | -3.30 | [1 - 3] |
quickRatioTTM | 0.645 | 0.800 | -0.914 | -0.731 | [0.8 - 2.5] |
cashRatioTTM | -0.176 | 1.500 | -2.09 | -3.13 | [0.2 - 2] |
debtRatioTTM | 0.290 | -1.500 | 5.17 | -7.76 | [0 - 0.6] |
interestCoverageTTM | 9.20 | 1.000 | 7.70 | 7.70 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.687 | 2.00 | 9.44 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.103 | 2.00 | 9.45 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.544 | -1.500 | 7.83 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.809 | 1.809 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.169 | 1.000 | 8.62 | 8.62 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.233 | 1.000 | 9.82 | 9.82 | [0.2 - 2] |
assetTurnoverTTM | 0.401 | 0.800 | -0.660 | -0.528 | [0.5 - 2] |
Total Score | 8.53 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 59.66 | 1.000 | 4.08 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0934 | 2.50 | -0.0471 | -0.110 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.103 | 2.00 | 9.63 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.687 | 2.00 | 9.44 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.00790 | 1.500 | 9.92 | -9.92 | [0 - 1] |
pegRatioTTM | 0.676 | 1.500 | 8.83 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.168 | 1.000 | 8.29 | 0 | [0.1 - 0.5] |
Total Score | 5.22 |
Boston Scientific
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа